Treatment efficacy in a soman-poisoned guinea pig model: added value of physostigmine?

scientific article published on September 15, 2010

Treatment efficacy in a soman-poisoned guinea pig model: added value of physostigmine? is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00204-010-0571-3
P953full work available at URLhttps://link.springer.com/content/pdf/10.1007/s00204-010-0571-3.pdf
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20842348/?tool=EBI
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20842348/pdf/?tool=EBI
https://europepmc.org/articles/PMC3043258
https://europepmc.org/articles/PMC3043258?pdf=render
http://link.springer.com/content/pdf/10.1007/s00204-010-0571-3
P932PMC publication ID3043258
P698PubMed publication ID20842348
P5875ResearchGate publication ID46274082

P50authorMarloes J A JoosenQ89613304
P2093author name stringAugust B. Smit
Herman P. M. van Helden
P2860cites workEfficacy of biperiden and atropine as anticonvulsant treatment for organophosphorus nerve agent intoxicationQ28139690
Protective activity of adenosine receptor agonists in the treatment of organophosphate poisoningQ33763414
Effective countermeasure against poisoning by organophosphorus insecticides and nerve agentsQ34999015
Nerve agents: a comprehensive reviewQ35702187
Future considerations for the medical management of nerve-agent intoxicationQ35772474
The protection of primates against soman poisoning by pretreatment with pyridostigmineQ39257982
Long-term cognitive deficits accompanied by reduced neurogenesis after soman poisoningQ40016744
The prophylactic use of 1-methyl, 2-hydroxyiminomethylpyridinium methanesulfonate (P2S) in the treatment of organophosphate poisoningQ40075996
Development of next generation medical countermeasures to nerve agent poisoningQ40287810
Cholinesterase inhibition: complexities in interpretation.Q40381861
Pharmacological effects of oximes: how relevant are they?Q40956431
Acetylcholinesterase inhibition by (+)physostigmine and efficacy against lethality induced by somanQ41218755
Presynaptic cholinergic inhibition in hippocampal culturesQ41916652
Adenosine A1 receptor agonist N6-cyclopentyladenosine affects the inactivation of acetylcholinesterase in blood and brain by sarinQ44327445
Anticholinergic and antiglutamatergic agents protect against soman-induced brain damage and cognitive dysfunctionQ44495554
Galantamine is a novel post-exposure therapeutic against lethal VX challenge.Q45914387
Toxicodynamic analysis of the combined cholinesterase inhibition by paraoxon and methamidophos in human whole bloodQ46048512
Pre-junctional effects of oximes on [3H]-acetylcholine release in rat hippocampal slices during soman intoxicationQ46557262
A structure-activity analysis of the variation in oxime efficacy against nerve agentsQ46571355
The protection of animals against organophosphate poisoning by pretreatment with a carbamateQ46586307
Comparative evaluation of benzodiazepines for control of soman-induced seizuresQ46601073
M(1)/M(3) and M(2)/M(4) muscarinic receptor double-knockout mice present distinct respiratory phenotypesQ46800154
Allosteric site in M2 acetylcholine receptors: evidence for a major conformational change upon binding of an orthosteric agonist instead of an antagonistQ46857215
Acetylcholinesterase inhibition: does it explain the toxicity of organophosphorus compounds?Q46939132
A novel approach for medical countermeasures to nerve agent poisoning in the guinea-pigQ46951899
Kinetic, equilibrium, and spectroscopic studies on dealkylation ("aging") of alkyl organophosphonyl acetylcholinesterase. Electrostatic control of enzyme topography.Q47646430
Comparison of the therapeutic effects and pharmacokinetics of HI-6, HLö-7, HGG-12, HGG-42 and obidoxime following non-reactivatable acetylcholinesterase inhibition in ratsQ48212219
Reversible and irreversible inhibition of rat brain muscarinic receptors is related to different substitutions on bisquaternary pyridinium oximesQ48449415
Anticonvulsants for nerve agent-induced seizures: The influence of the therapeutic dose of atropineQ48657783
Neurochemical mechanisms in soman-induced seizuresQ48663828
In vivo cholinesterase inhibitory specificity of organophosphorus nerve agentsQ48713985
Anticonvulsant treatment of nerve agent seizures: anticholinergics versus diazepam in soman-intoxicated guinea pigs.Q51426685
A comparison of the decarbamoylation rates of physostigmine-inhibited plasma and red cell cholinesterases of man with other species.Q53858279
In vitro studies on the reactivation by oximes of phosphylated acetylcholinesterase--I. On the reactions of P2S with various organophosphates and the properties of the resultant phosphylated oximesQ70026135
Allosteric regulation of the binding of [3H]acetylcholine to m2 muscarinic receptorsQ71951710
Sarin poisoning in Tokyo subwayQ72152668
P433issue3
P407language of work or nameEnglishQ1860
P921main subjectanimal modelQ264024
P304page(s)227-237
P577publication date2010-09-15
P1433published inArchives of ToxicologyQ635837
P1476titleTreatment efficacy in a soman-poisoned guinea pig model: added value of physostigmine?
P478volume85